We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$419B
1-Year Est. Return
43.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.14%
AUM
$382B
AUM Growth
+$3.03B
(+0.8%)
Cap. Flow
-$4.9B
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
34.7%
Holding
3,317
New
65
Increased
1,141
Reduced
1,398
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$2.55B |
| 2 |
NHYB
Nuveen High Yield Corporate Bond ETF
NHYB
|
+$1.61B |
| 3 |
Apple
AAPL
|
+$732M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$567M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.96B |
| 2 |
NVIDIA
NVDA
|
+$842M |
| 3 |
Amazon
AMZN
|
+$783M |
| 4 |
Microsoft
MSFT
|
+$646M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$602M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33% |
| 2 | Financials | 12.48% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORKA
2151
Oruka Therapeutics
ORKA
$7.05B
| $2.62M | ﹤0.01% |
86,347
+51,034
| +145% | +$1.42M |
|
|
BBNX
2152
Beta Bionics
BBNX
$812M
| $2.6M | ﹤0.01% |
85,379
+31,889
| +60% | +$852K |
|
|
LIF
2153
Life360
LIF
$4.01B
| $2.6M | ﹤0.01% |
40,530
+5,987
| +17% | +$497K |
|
2154
American Express Global Business Travel
GBTG
$4.94B
| $2.59M | ﹤0.01% |
338,603
+41,549
| +14% | +$322K |
|
2155
CRA International
CRAI
$1.05B
| $2.58M | ﹤0.01% |
12,868
-705
| -5% | -$133K |
|
2156
Dime Commercial Bancshares
DCOM
$1.82B
| $2.58M | ﹤0.01% |
85,755
+3,194
| +4% | +$92.3K |
|
|
EFC
2157
Ellington Financial
EFC
$1.77B
| $2.58M | ﹤0.01% |
189,737
| – | – |
|
2158
Vanda Pharmaceuticals
VNDA
$305M
| $2.57M | ﹤0.01% |
291,473
+120,428
| +70% | +$663K |
|
2159
Surgery Partners
SGRY
$1.99B
| $2.56M | ﹤0.01% |
165,747
-4,126
| -2% | -$75.8K |
|
2160
Safety Insurance
SAFT
$1.52B
| $2.56M | ﹤0.01% |
32,851
| – | – |
|
2161
Liberty Global Class C
LBTYK
$3.44B
| $2.56M | ﹤0.01% |
231,600
| – | – |
|
2162
Relay Therapeutics
RLAY
$4.39B
| $2.54M | ﹤0.01% |
300,464
+12,014
| +4% | +$85.7K |
|
2163
Bank First Corp
BFC
$1.75B
| $2.53M | ﹤0.01% |
20,802
-601
| -3% | -$76.6K |
|
2164
Enovix
ENVX
$1B
| $2.52M | ﹤0.01% |
345,197
| – | – |
|
|
CIM
2165
Chimera Investment
CIM
$1B
| $2.52M | ﹤0.01% |
202,767
| – | – |
|
|
SILA
2166
DELISTED
Sila Realty Trust
SILA
| $2.52M | ﹤0.01% |
108,116
| – | – |
|
2167
Navitas Semiconductor
NVTS
$3.6B
| $2.49M | ﹤0.01% |
349,087
-152,021
| -30% | -$1.46M |
|
2168
CS Disco
LAW
$290M
| $2.47M | ﹤0.01% |
318,672
+207,700
| +187% | +$1.46M |
|
2169
PRA Group
PRAA
$780M
| $2.47M | ﹤0.01% |
139,528
+12,089
| +9% | +$188K |
|
|
GPGI
2170
GPGI Inc
GPGI
$3.84B
| $2.46M | ﹤0.01% |
127,761
+66,660
| +109% | +$1.33M |
|
2171
Core Laboratories
CLB
$573M
| $2.46M | ﹤0.01% |
153,515
-1,891
| -1% | -$28.1K |
|
2172
Marcus & Millichap
MMI
$1.18B
| $2.46M | ﹤0.01% |
90,102
+36,883
| +69% | +$1.07M |
|
2173
Navient
NAVI
$864M
| $2.46M | ﹤0.01% |
189,125
-6,249
| -3% | -$77.8K |
|
2174
Personalis
PSNL
$1.52B
| $2.46M | ﹤0.01% |
308,680
| – | – |
|
2175
Leggett & Platt
LEG
$1.32B
| $2.45M | ﹤0.01% |
223,102
-195,352
| -47% | -$1.92M |
|
Similar funds
VFT
Nuveen's Q4 2025 Portfolio in Review
As of Q4 2025, Nuveen held 3,317 positions worth $382B, up 0.8% from $379B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4%. Nuveen opened 65 new positions and exited 67, leaving the 3,317-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q4 2025 buy was TotalEnergies: 5,227,521 shares worth $341M.
- Nuveen added most to Nuveen International Aggregate Bond ETF in Q4 2025, an estimated $2.55B increase.
- Nuveen's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $1.96B.
- Nuveen fully exited Janus Henderson AAA CLO ETF in Q4 2025, selling an estimated $602M.
- Nuveen's ten largest holdings make up 35% of its $382B portfolio in Q4 2025.
- Nuveen opened 65 new positions and closed 67 in Q4 2025.
- Nuveen's portfolio value rose 0.8% quarter-over-quarter to $382B.
Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.